With regard to bacterial resistance, the topical use of chemical antis
eptics is becoming increasingly important as an alternative to antibio
tics. In this paper, a topical antiseptic (Lavasept(R)(1)) which has b
een adequately verified by experimental and clinical investigations is
presented. Its bactericidal effects are reliable even in the presence
of proteins and whole blood; it has high tissue and general tolerance
, very low toxicity, does not provoke bacterial resistance, and there
is no measureable resorption. The substance is free from iodine, heavy
metal salts, PVP, and aldehyde. It is a combination of biguanide (bac
tericidal component) and polyethyleneglycol which reduces the surface
tension of the biguanide and ensures uniform moistening of the wound.
This substance has proven to be a promising auxiliary agent to correct
surgery in the treatment of various surgical infections of the soft t
issue, fresh and chronic infections of the bone, in war surgery (1), a
nd for prophylactic irrigation during operations with a high risk of i
nfection (e.g. change of endoprosthesis, repair of open fractures). Th
e contraindication, as for any topical antiseptic, is the irrigation o
f aseptic joints.